CRWV stockholder (NASDAQ: CRWV) details Form 144 and recent 10b5-1 sales
Rhea-AI Filing Summary
A stockholder of CRWV filed a notice of proposed sale on Form 144 covering 3,000 shares of common stock. The shares, originally acquired as Founders Shares on February 25, 2019, are slated for potential sale through Morgan Stanley Smith Barney LLC with an aggregate market value of $266,640.00 as of July 13, 2026 on NASDAQ. The filing also lists extensive Rule 10b5-1 share sales by related parties and trusts over the past three months, including multiple blocks of up to 200,000 shares of common stock.
Positive
- None.
Negative
- None.
Filing Explained
The July 13 notice covers a proposed resale of 3,000 existing shares, with no reported new issuance, dilution, or company cash proceeds.
The July 13 Form 144 identifies a proposed sale of 3,000 CoreWeave common shares through Morgan Stanley with a reported value of
The filing separately labels its prior-sales entries as 10b5-1 sales, while the 3,000-share notice itself carries no such label. Under the supplied definition, a 10b5-1 plan is a written trading plan adopted in advance that executes trades on a schedule or formula, and its adoption date does not state reasons for individual trades.
The supplied 90-day insider record reports 10 sale transactions totaling 72,265 shares and no purchases; that history does not establish that the 3,000 shares in this notice were sold. The notice itself leaves completion unresolved: it identifies securities to be sold but provides no completed-sale entry for this filing.
Sources and calculations
- CoreWeave Form 144 (2026-07-13)
- Rule 10b5-1 plan definition (2026-07-12)
- CoreWeave recent insider transaction record (90-day record)
Key Figures
Key Terms
Form 144 regulatory
Rule 10b5-1 regulatory
irrevocable trust financial
GRAT financial
AI-generated analysis. How Rhea-AI works. Not financial advice.